Download PDF
Thromb Haemost 2007; 97(06): 1054-1056
DOI: 10.1160/TH07-01-0056
Letters to the Editor
Schattauer GmbH

Gallic acid, a dietary polyphenolic component, blunts the inhibition of platelet COX-1 by aspirin: Preliminary in-vitro findings

Marilena Crescente
1   Laboratory of Cell Biology and Pharmacology of Thrombosis, Research Laboratories, “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
,
Chiara Cerletti
1   Laboratory of Cell Biology and Pharmacology of Thrombosis, Research Laboratories, “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
,
Giovanni de Gaetano
1   Laboratory of Cell Biology and Pharmacology of Thrombosis, Research Laboratories, “John Paul II” Centre for High Technology Research and Education in Biomedical Sciences, Catholic University, Campobasso, Italy
› Author AffiliationsFinancial support: This work was partially supported by MIUR (Programma Triennale Ricerca, decreto 1588).
Further Information

Publication History

Received: 25 January 2007

Accepted after revision 07 March 2007

Publication Date:
27 November 2017 (online)

    Permissions and Reprints

 

 

  • References

  • 1 Ohno Y, Fukuda K, Takemura G. et al Induction of apoptosis by gallic acid in lung cancer cells. Anticancer Drugs 1999; 10: 845-851.
    CrossrefPubMedGoogle Scholar
  • 2 Appeldoorn CC, Bonnefoy A, Lutters BC. et al Gallic acid antagonizes P-selectin-mediated plateletleukocyte interactions: implications for the French paradox. Circulation 2005; 111: 106-112.
    CrossrefPubMedGoogle Scholar
  • 3 de Gaetano G, Cerletti C, Dejana E. et al Pharmacology of platelet inhibition in humans: implications of the salicylate-aspirin interaction. Circulation 1985; 72: 1185-1193.
    CrossrefPubMedGoogle Scholar
  • 4 Livio M, Del Maschio A, Cerletti C. et al Indomethacin prevents the long-lasting inhibitory effect of aspirin on human platelet cyclo-oxygenase activity. Prostaglandins 1982; 23: 787-796.
    CrossrefPubMedGoogle Scholar
  • 5 MacDonald TM, Wei L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet 2003; 361: 573-574.
    CrossrefPubMedGoogle Scholar
  • 6 Shahrzad S, Aoyagi K, Winter A. et al Pharmacokinetics of gallic acid and its relative bioavailability from tea in healthy humans. J Nutr 2001; 131: 1207-1210.
    CrossrefPubMedGoogle Scholar
  • 7 Kuriyama S, Shimazu T, Ohmori K. et al Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. J Am Med Assoc 2006; 296: 1255-1265.
    CrossrefPubMedGoogle Scholar
  • 8 Trichopoulou A, Costacou T, Bamia C. et al Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med 2003; 348: 2599-2608.
    CrossrefPubMedGoogle Scholar
  • 9 Konishi Y, Hitomi Y, Yoshioka E. Intestinal absorption of p-coumaric and gallic acids in rats after oral administration. J Agric Food Chem 2004; 52: 2527-2532.
    CrossrefPubMedGoogle Scholar
  • 10 de Gaetano G, Cerletti C. Aspirin resistance: a revival of platelet aggregation tests?. J Thromb Haemost 2003; 1: 2048-2061.
    CrossrefPubMedGoogle Scholar
  • 11 Maree AO, Fitzgerald DJ. Aspirin and coronary artery disease. Thromb Haemost 2004; 92: 1175-1181.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 12 Szczeklik A, Musial J, Undas A. et al Aspirin resistance. J Thromb Haemost 2005; 3: 1655-1662.
    CrossrefPubMedGoogle Scholar
  • 13 Hankey GJ, Eikelboom JW. Aspirin resistance. Lancet 2006; 367: 606-617.
    CrossrefPubMedGoogle Scholar